Paul J Rosenfield, MD

Clinical Focus

• Adjustment Disorder
• Anxiety
• Attention Deficit Hyperactivity Disorder And Attention Deficit Disorder
• Bipolar Disorder
• Borderline Personality Disorder
• Depression
• Dysthymia
• Generalized Anxiety Disorder
• Mental Health Services

Show More

• Adjustment Disorder
• Anxiety
• Attention Deficit Hyperactivity Disorder And Attention Deficit Disorder
• Bipolar Disorder
• Borderline Personality Disorder
• Depression
• Dysthymia
• Generalized Anxiety Disorder
• Mental Health Services
• Panic Disorder
• Personality Disorders
• Post-Traumatic Stress Disorder
• Psychotherapy
• Schizophrenia
• Stress Management/Anxiety Disorders

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:9

Article:16

Review Article:1

Comment/Debate:1

Letter:2

Recent Artifacts

• Childhood adversity and psychotic disorders: Epidemiological evidence, theoretical models and clinical considerations
• Insights from Expanded Adverse Childhood Experiences Screening in a Hospital-Based Outpatient Psychiatry Service
• Facial and Vocal Markers of Schizophrenia Measured Using Remote Smartphone Assessments: Observational Study
• Letter to the Editor
• Computer Vision-Based Assessment of Motor Functioning in Schizophrenia: Use of Smartphones for Remote Measurement of Schizophrenia Symptomatology
• Associations between clinicians' emotional responses, therapeutic alliance, and patient suicidal ideation
• The Modular Assessment of Risk for Imminent Suicide (MARIS): A validation study of a novel tool for suicide risk assessment
• Determinants and Predictive Value of Clinician Assessment of Short-Term Suicide Risk
• Emotional pain mediates the link between preoccupied attachment and non-suicidal self-injury in high suicide risk psychiatric inpatients
• Complex PTSD in ICD-11: A Case Report on a New Diagnosis

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Rosenfield did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.